Lymphoma & Plasma Cell Disorders
News
OK to treat many cancer patients despite pandemic, says ESMO
ESMO recommends against stopping or delaying cancer treatment that can impact survival.
Conference Coverage
Higher death rate seen in cancer patients with nosocomial COVID-19
All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.
News
FDA okays new CAR T therapy, first for mantle cell lymphoma
Conference Coverage
CCC19, other registries help define COVID/cancer landscape
New data from CCC19 show an increased risk of death from COVID-19 among non-Hispanic black cancer patients and patients with hematologic...
News
Early screening may halve breast cancer mortality in childhood cancer survivors
A modeling study supports early breast cancer screening in women with a history of chest radiation.
News
Transitioning regimen may prolong proteasome inhibitor–based therapy for MM
Transitioning from parenteral bortezomib-based induction to all-oral ixazomib-lenalidomide-dexamethasone increased PI-based treatment adherence/...
Article
American Cancer Society update: ‘It is best not to drink alcohol’
Article
Can an app guide cancer treatment decisions during the pandemic?
Article
‘A good and peaceful death’: Cancer hospice during the pandemic
News
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
